Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74683317)
Watch
English
Expanding the options for risk-based therapy in febrile neutropenia
scientific article published on 01 June 1998
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Expanding the options for risk-based therapy in febrile neutropenia
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
author name string
K V Rolston
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
publication date
1 June 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
published in
Diagnostic Microbiology and Infectious Disease
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
volume
31
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
page(s)
411-416
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
cites work
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The changing epidemiology of infections at cancer hospitals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900034-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0732-8893(98)00034-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
PubMed publication ID
9635917
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9635917
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635917%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
